GRAVITY DIAGNOSTICS LLC NPI 1447601695

NPI Details

GRAVITY DIAGNOSTICS, LLC is a clinical medical laboratory in Covington, KY. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. GRAVITY DIAGNOSTICS, LLC NPI is 1447601695. The provider is registered as an organization entity type.

The provider's business location address is:

812 RUSSELL ST
COVINGTON, KY
ZIP 41011-165
Phone: (859) 757-0158
Fax: (859) 581-4086

The provider's authorized official is Anthony Remington .
The authorized official title is Ceo and has the following contact phone number (727) 200-4882.

The CLIA number assigned to this NPI record is 18D1100471 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Analysis for antibody, treponema pallidum (HCPCS:86780)
• Bacterial colony count, urine (HCPCS:87086)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Acute hepatitis panel (HCPCS:80074)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Hepatitis c antibody measurement (HCPCS:86803)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Hemoglobin a1c level (HCPCS:83036)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Liver function blood test panel (HCPCS:80076)
• Vitamin d-3 level (HCPCS:82306)
• Detection test by nucleic acid for hepatitis c virus, quantification (HCPCS:87522)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Liver enzyme (sgot), level (HCPCS:84450)
• Total protein level, blood (HCPCS:84155)
• Bilirubin level, total (HCPCS:82247)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Bilirubin level, direct (HCPCS:82248)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Albumin (protein) level (HCPCS:82040)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Testosterone (hormone) level, total (HCPCS:84403)
• Molecular pathology procedure (HCPCS:81479)
• Magnesium level (HCPCS:83735)
• Urine pregnancy test (HCPCS:81025)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Prolactin (milk producing hormone) level (HCPCS:84146)
• Uric acid level, blood (HCPCS:84550)
• Bacterial urine culture (HCPCS:87088)

The enumeration date for this NPI number is 6/29/2016 and was last updated on 3/1/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: